Home › Companies › Arrowhead Pharmaceuticals, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Arrowhead Pharmaceuticals, Inc.’s Form 8-K, filed March 20, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of March 19, 2026: 7 items on Arrowhead Pharmaceuticals, Inc.’s Form 8-K, filed March 20, 2026: 7 passed (calculated).
Significant dissent: 1 director (30.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Arrowhead Pharmaceuticals, Inc. in the interactive database Compare manager voting policies
These tallies are Arrowhead Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed March 20, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Christopher Anzalon | 100,146,366 | 1,622,011 | 77,607 | -- | 17,955,558 | 98% | Passed (calculated) | — |
| Elect Director: Mauro Ferrar | 99,784,848 | 1,986,678 | 74,458 | -- | 17,955,558 | 98% | Passed (calculated) | — |
| Elect Director: Hongbo L | 92,692,428 | 8,971,012 | 182,544 | -- | 17,955,558 | 91% | Passed (calculated) | — |
| Elect Director: Adeoye Olukoto | 100,808,855 | 852,631 | 184,498 | -- | 17,955,558 | 99.2% | Passed (calculated) | — |
| Elect Director: Michael Perr | 70,427,879 | 31,342,814 | 75,291 | -- | 17,955,558 | 69% | Passed (calculated) | — |
| Elect Director: Victoria Vakiene | 99,264,191 | 2,506,051 | 75,742 | -- | 17,955,558 | 98% | Passed (calculated) | — |
| Elect Director: William Waddill | 91,907,466 | 9,861,644 | 256,341 | -- | 17,955,558 | 90% | Passed (calculated) | — |
Source: Arrowhead Pharmaceuticals, Inc., Form 8-K, filed with the SEC on March 20, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
377 asset managers disclosed a vote on at least one Arrowhead Pharmaceuticals, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Arrowhead Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
The 107 asset managers below reported 50,336,475 for, 10,960 against, 25,221 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,302,610 | 3 | 1 | 0 | For |
| Fidelity | 6,850,753 | 0 | 0 | 0 | For |
| State Street | 3,210,798 | 0 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 399,092 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| JPMorgan | 172,368 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,648 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. All 107 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Christopher Anzalone
Arrowhead Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Christopher Anzalon”): 100,146,366 for, 1,622,011 against, per its Form 8-K filed March 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 50,336,391 for, 11,043 against, 25,220 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,302,608 | 5 | 0 | 0 | For |
| Fidelity | 6,850,753 | 0 | 0 | 0 | For |
| State Street | 3,210,717 | 81 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 399,092 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| JPMorgan | 172,368 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,648 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. All 107 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Mauro Ferrari
Arrowhead Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Mauro Ferrar”): 99,784,848 for, 1,986,678 against, per its Form 8-K filed March 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 50,298,877 for, 48,558 against, 25,220 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,302,607 | 6 | 0 | 0 | For |
| Fidelity | 6,850,753 | 0 | 0 | 0 | For |
| State Street | 3,210,622 | 176 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 399,092 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| JPMorgan | 172,368 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,648 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. All 107 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
59% of fund votes cast · no official result
The 107 asset managers below reported 29,457,122 for, 20,890,313 against, 25,220 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 263,853 | 14,510,585 | 0 | 0 | Against |
| Vanguard | 14,302,575 | 38 | 0 | 0 | For |
| Fidelity | 2,843,919 | 4,006,834 | 0 | 0 | Mixed |
| State Street | 3,210,622 | 176 | 0 | 0 | For |
| Charles Schwab | 0 | 1,191,957 | 0 | 0 | Against |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 438,138 | 25,480 | 0 | 0 | Mixed |
| Jackson National | 118,615 | 280,477 | 0 | 0 | Mixed |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 114,090 | 195,680 | 0 | 0 | Mixed |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 218,394 | 0 | 0 | Against |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 172,368 | 0 | 0 | Against |
| Lincoln Financial | 161,298 | 10,350 | 0 | 0 | Mixed |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. All 107 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Victoria Vakiener
Arrowhead Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Victoria Vakiene”): 99,264,191 for, 2,506,051 against, per its Form 8-K filed March 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 50,336,470 for, 10,965 against, 25,220 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,302,605 | 8 | 0 | 0 | For |
| Fidelity | 6,850,753 | 0 | 0 | 0 | For |
| State Street | 3,210,798 | 0 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 399,092 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| JPMorgan | 172,368 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,648 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. All 107 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 90.6% for (March 12, 2025 meeting) ▼ 0.3 pts
Description as filed by funds: Election of Directors: William Waddill
Arrowhead Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: William Waddill”): 91,907,466 for, 9,861,644 against, per its Form 8-K filed March 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 45,773,446 for, 4,573,989 against, 25,220 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,290,441 | 12,172 | 0 | 0 | For |
| Fidelity | 2,897,410 | 3,953,343 | 0 | 0 | Mixed |
| State Street | 3,210,798 | 0 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 118,615 | 280,477 | 0 | 0 | Mixed |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 172,368 | 0 | 0 | Against |
| Lincoln Financial | 161,298 | 10,350 | 0 | 0 | Mixed |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. All 107 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
91% of fund votes cast · no official result
The 103 asset managers below reported 45,640,914 for, 4,379,099 against, 25,220 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,281,142 | 0 | 0 | 0 | For |
| Fidelity | 2,897,410 | 3,953,343 | 0 | 0 | Mixed |
| State Street | 3,210,798 | 0 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 118,615 | 280,477 | 0 | 0 | Mixed |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| Lincoln Financial | 161,298 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
| Putnam | 126,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. All 103 are in the interactive database (link above).
99.9% of fund votes cast · no official result
Description as filed by funds: APPROVAL OF THE ARROWHEAD PHARMACEUTICALS, INC. AMENDED AND RESTATED 2021 INCENTIVE PLAN.
The 108 asset managers below reported 50,117,069 for, 57,988 against, 27,721 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,302,605 | 7 | 1 | 0 | For |
| Fidelity | 6,850,753 | 0 | 0 | 0 | For |
| State Street | 3,210,622 | 176 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 399,092 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,648 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
| Putnam | 126,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. All 108 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
36% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 263,853 | 14,510,585 | 0 | 0 | Against |
| Vanguard | 5,758,316 | 8,544,297 | 1 | 0 | Mixed |
| Fidelity | 2,840,001 | 4,010,752 | 0 | 0 | Mixed |
| State Street | 3,206,955 | 3,843 | 0 | 0 | For |
| Charles Schwab | 0 | 1,191,957 | 0 | 0 | Against |
| ALGER INSTITUTIONAL FUNDS | 0 | 804,346 | 0 | 0 | Against |
| ALGER FUNDS | 0 | 732,137 | 0 | 0 | Against |
| Invesco | 0 | 710,966 | 0 | 0 | Against |
| T. Rowe Price | 0 | 597,841 | 0 | 0 | Against |
| Bridge Builder Trust | 28,891 | 434,727 | 0 | 0 | Mixed |
| Jackson National | 0 | 399,092 | 0 | 0 | Against |
| ALGER FUNDS II | 0 | 374,810 | 0 | 0 | Against |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 0 | 359,465 | 0 | 0 | Against |
| Equitable | 0 | 309,770 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 0 | 246,088 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 221,653 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 218,394 | 0 | 0 | Against |
| Legg Mason | 0 | 203,339 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 193,603 | 0 | 0 | Against |
| Lincoln Financial | 91,232 | 80,416 | 0 | 0 | Mixed |
| First Trust | 0 | 141,976 | 0 | 0 | Against |
| ALGER PORTFOLIOS | 0 | 132,661 | 0 | 0 | Against |
| Putnam | 0 | 126,400 | 0 | 0 | Against |
Fund voting reports, all 105 managers: 13,399,436 for, 36,662,706 against, 25,221 abstained, 224 mixed. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 7,371,301 | 0 | 0 | 0 | For |
| Fidelity | 0 | 6,718,013 | 0 | 0 | Against |
| State Street | 5,807,294 | 49,413 | 0 | 0 | For |
| BlackRock | 472,633 | 4,499,905 | 0 | 0 | Mixed |
| GEODE CAPITAL MANAGEMENT, LLC | 3,271,084 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 0 | 2,564,143 | 0 | 0 | Against |
| Janus Henderson | 0 | 2,468,624 | 0 | 0 | Against |
| Siren, L.L.C. | 1,615,476 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,591,559 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,356,007 | 0 | 0 | Against |
| Invesco | 0 | 1,321,542 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 1,189,439 | 0 | 0 | Against |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 1,170,616 | 0 | 0 | Against |
| Northern Trust | 1,103,292 | 66,455 | 0 | 0 | Mixed |
| Vanguard | 1,011,100 | 127,769 | 0 | 0 | Mixed |
| T. Rowe Price | 0 | 1,000,276 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 857,633 | 0 | 0 | Against |
| Fisher Asset Management, LLC | 0 | 811,995 | 0 | 0 | Against |
| UBS | 0 | 795,961 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 0 | 716,457 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 697,700 | 0 | 0 | Against |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 595,400 | 0 | 0 | Against |
| RTW INVESTMENTS, LP | 585,682 | 0 | 0 | 0 | For |
| Voya | 0 | 496,959 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 483,147 | 0 | 0 | 0 | For |
Institutional-manager reports, all 296 managers: 26,124,383 for, 34,266,742 against, 26,360 abstained, 763 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.9% of fund votes cast · no official result
Description as filed by funds: RATIFICATION OF THE SELECTION OF KPMG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2026.
The 104 asset managers below reported 50,052,516 for, 1 against, 25,220 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,774,438 | 0 | 0 | 0 | For |
| Vanguard | 14,302,612 | 1 | 0 | 0 | For |
| Fidelity | 6,850,753 | 0 | 0 | 0 | For |
| State Street | 3,210,798 | 0 | 0 | 0 | For |
| Charles Schwab | 1,191,957 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 804,346 | 0 | 0 | 0 | For |
| ALGER FUNDS | 732,137 | 0 | 0 | 0 | For |
| Invesco | 710,966 | 0 | 0 | 0 | For |
| T. Rowe Price | 597,841 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 463,618 | 0 | 0 | 0 | For |
| Jackson National | 399,092 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 374,810 | 0 | 0 | 0 | For |
| TIAA | 371,985 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 370,000 | 0 | 0 | 0 | For |
| Voya | 359,465 | 0 | 0 | 0 | For |
| Equitable | 309,770 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 246,088 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 221,653 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 218,394 | 0 | 0 | 0 | For |
| Legg Mason | 203,339 | 0 | 0 | 0 | For |
| Prudential/PGIM | 193,603 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,648 | 0 | 0 | 0 | For |
| First Trust | 141,976 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 132,661 | 0 | 0 | 0 | For |
| Putnam | 126,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 104 asset managers. All 104 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 137,391,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 10.75% |
| 2 | Vanguard | 10.41% |
| 3 | Fidelity | 4.99% |
| 4 | State Street | 2.34% |
| 5 | Charles Schwab | 0.87% |
| 6 | ALGER INSTITUTIONAL FUNDS | 0.59% |
| 7 | ALGER FUNDS | 0.53% |
| 8 | Invesco | 0.52% |
| 9 | T. Rowe Price | 0.44% |
| 10 | Bridge Builder Trust | 0.34% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Avoro Capital Advisors LLC | 5.37% |
| 2 | Fidelity | 4.89% |
| 3 | State Street | 4.26% |
| 4 | BlackRock | 3.62% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.38% |
| 6 | FRED ALGER MANAGEMENT, LLC | 1.87% |
| 7 | Janus Henderson | 1.80% |
| 8 | Siren, L.L.C. | 1.18% |
| 9 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.16% |
| 10 | Charles Schwab | 0.99% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 18,161,519 | 13.22% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 15,293,121 | 11.13% | Form 13F, quarter ended March 31, 2026 |
| Entities affiliated with Avoro Capital Advisors LLC | 13,985,269 | 10.18% | Proxy statement (DEF 14A), proxy filed January 27, 2026 |
| Avoro Capital Advisors LLC | 13,823,383 | 10.06% | Schedule 13G, filed August 14, 2026 |
| FMR (Fidelity) | 7,266,652 | 5.29% | Form 13F, quarter ended March 31, 2026 |
| State Street | 6,496,130 | 4.73% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 4,278,828 | 3.11% | Form 13F, quarter ended March 31, 2026 |
| Christopher Anzalone | 3,792,739 | 2.76% | Proxy statement (DEF 14A), proxy filed January 27, 2026 |
| Invesco | 3,280,647 | 2.39% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,739,923 | 1.27% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 137,391,000 shares outstanding, as reported by Arrowhead Pharmaceuticals, Inc. on its Form 10-Q dated December 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Arrowhead Pharmaceuticals, Inc.'s shareholder meeting held March 19, 2026, in the 2025-2026 proxy season, 377 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 3,827 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Arrowhead Pharmaceuticals, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. — the reporting funds and managers cast 36% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arrowhead Pharmaceuticals, Inc.’s 10-Q dated December 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Arrowhead Pharmaceuticals, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Arrowhead Pharmaceuticals (ARWR) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/arrowhead-pharmaceuticals-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.